טוען...
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
A debate about the market-leading influenza antiviral medication, oseltamivir, which initially focused on treatment for generally mild illness, has been expanded to question the wisdom of stockpiling for use in future influenza pandemics. Although randomized controlled trial evidence confirms that o...
שמור ב:
| הוצא לאור ב: | Emerg Infect Dis |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Centers for Disease Control and Prevention
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4880079/ https://ncbi.nlm.nih.gov/pubmed/27191818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2206.151037 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|